Revolutionizing mental and cognitive health screening through AI-driven analysis of voice as a real-time vital sign.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Canary Speech is a health-tech startup pioneering AI-powered vocal biomarker analysis to non-invasively detect behavioral and cognitive health conditions—such as stress, mood, and early-stage neurodegeneration—simply from brief conversational speech. It transforms subjective wellness screening into real-time, objective insight through its secure, HIPAA-compliant API infrastructure.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Canary Speech Management Team
Canary Speech Valuations & Financials
View real-time NPM data on Canary Speech stock including daily Canary Speech stock price estimates, valuation history, and historical share price information. Access Canary Speech financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Canary Speech pricing across six independent market signals. Looking for private company due diligence data sources on Canary Speech? Get in touch to learn more.
Similar Companies
like Canary Speech
Earli
Healthcare & Life Sciences
Forces cancer cells to produce a synthetic biomarker, enabling precise PET scan detection through gene therapy-based Synthetic Biopsy.
SCG Cell Therapy
Healthcare & Life Sciences
Develops immunotherapy treatments for chronic infections and cancers using T-cell receptor technology to enhance immune system response.
Differentiated Therapeutics
Healthcare & Life Sciences
Develops novel protein degrader therapeutics using an AI-driven platform to target and eliminate disease-causing proteins.
tab32
Healthcare & Life Sciences
Delivers a platform that manages dental operations, patient data, and billing while improving workflows and practice performance.
Lucem Health
Healthcare & Life Sciences
Delivers AI solutions that integrate with clinical workflows to identify high-risk, undertreated patients and enable earlier disease detection.
Scimar
Healthcare & Life Sciences
Biotech company develops innovative solutions for type-II diabetes prevention, detection and treatment while advancing metabolic health research.
InterVenn
Healthcare & Life Sciences
Delivers artificial intelligence-driven glycoproteomic analysis to accelerate early disease detection and clinical biomarker discovery for personalized medicine.
Matter Neuroscience
Healthcare & Life Sciences
Helps individuals boost happiness by analyzing neurotransmitters and offering app-based tools to track and improve well-being.
Homeward Health
Healthcare & Life Sciences
Expands rural healthcare access by combining local teams, technology, and partners to deliver personalized, coordinated care.
FAQ
We have answers
Canary Speech stock does not trade on public stock exchanges. Canary Speech stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Canary Speech stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Canary Speech Stock does not trade on public stock exchanges. In order to sell Canary Speech shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Canary Speech does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Canary Speech share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Canary Speech stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Canary Speech stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Canary Speech stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Canary Speech is a private company and has not had an IPO. There is currently no Canary Speech IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Canary Speech IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
